|
University of Iowa Diagnostic Laboratories (UIDL) Test Directory 319-384-7212 (local) 1-866-844-2522 (toll free) |
|
| Thyroxine (T-4) | |
| Order Code: T4
Order Form: Laboratory Requisition |
Specimen: |
Plasma | ||
Collection Medium: |
| ||
Alternate Collection Media: |
Call laboratory for additional acceptable specimen collection containers. | ||
Minimum: |
2 mls whole blood in light green top or two 0.6 ml microtubes | ||
Testing Schedule: |
24 hrs/day, 7 days a week, including holidays. | ||
Analytic Time: |
3 hours (upon receipt in laboratory) | ||
Reference Range: |
AGE MALES/FEMALES
0 - 3 days 8.0-20.0 mcg/dL
3 - 30 days 5.0-15.0 mcg/dL
31 days - 1 years 6.0-14.0 mcg/dL
1 - 5 years 4.5-11.0 mcg/dL
6 - 18 years 4.5-10.0 mcg/dL
Normal adults 4.6 12.0 mcg/dL | ||
Comments: |
Please print, complete and submit the Advance Beneficiary Notice (ABN) along with the Laboratory Requisition before shipping the specimen. New analytical immunoassay with different references ranges instituted 4/24/00 at 1000. | ||
Test Limitations: |
The assay is unaffected by icterus (bilirubin is less than 37 mg/dl), hemolysis (Hb is less than 2.3 g/dl), lipemia (triglycerides is less than 2500 mg/dl) and biotin is less than 100 ng/ml (criterion: recovery within plus or minus 10% of initial value). In patients receiving therapy with high biotin doses (i.e. is greater than 5 mg/day) no sample should be taken until at least 8 hours after the last biotin administration. No interference was observed from rheumatoid factor (up to 2400 U/ml) and samples from dialysis patients. In vitro tests were performed on 15 commonly used pharmaceuticals. No interference with the assay was found. The test cannot be used to determine T4 in patients receiving treatment with lipid-lowering agents containing D-T4. If the thyroid function is to be checked in such patients, the therapy should first be interrupted for 4-6 weeks to allow the physiological state to become reestablished.* Autoantibodies to thyroid hormones can interfere with the assay. The risk of interference from potential immunological interactions between test components and rare plasma has been minimized by the inclusion of additives. In rare cases, interference due to extremely high titers of antibodies to ruthenium can occur. T4 reagent contains additives which minimize these effects. Extremely high titers of antibodies to streptavidin can occur in isolated cases and cause interference. For diagnostic purposes, the T4 findings should always be assessed in conjunction with the patient's medical history, clinical examination and other findings. *Bantle JP, Hunninghake DB, Frantz ID, Kuba K, Mariash CN, Oppenheimer JH. Comparison of Effectiveness of Thyrotropin-Suppressive Doses of D- and L-Thyroxine in Treatment of Hypercholesterolemia. Am J Med 1984;3:475-481. | ||
Methodology: |
Electrochemiluminescence Immunoassay | ||
Sample Processing: |
Centrifuge at 3000 RPM for 10 minutes. Aliquot plasma into labeled container and cap. | ||
Sample Storage: |
Room temperature or refrigerate if stored overnight, weekends or holidays. | ||
Transport Instructions: |
Place specimen into zip-lock type bag, seal bag. Place requisition into outside pocket of bag. Ship ambient or refrigerate. | ||
CPT Code: |
84436 | ||
See Additional Information: Thyroxine - Age Variation in Serum |
Updated: 04/14/2009